Genetic prediction of the effectiveness of biologics for psoriasis treatment
- 30 April 2016
- journal article
- research article
- Published by Wiley in The Journal of Dermatology
- Vol. 43 (11) , 1273-1277
Abstract
Anti‐tumor necrosis factor (TNF)‐α therapy is used for the treatment of psoriasis, with varying outcomes. However, the specific cause of inadequate response or treatment failure remains unknown. The aim of the present study was to identify useful clinical biomarkers for predicting therapeutic responses or to serve as new drug targets for refractory psoriasis cases. We performed a genome‐wide association study (GWAS) of 65 psoriasis patients who were prospectively followed after beginning anti‐TNF‐α therapy using Human Omni Express‐8 v1.2 Beadchips. Patients were enrolled at the dermatology departments of Kobe University Hospital and six collaborative hospitals. Associations between single nucleotide polymorphisms (SNP) and changes in the Psoriasis Area and Severity Index (PASI) after 12 weeks of treatment were evaluated. After genome data collection and quality control, a total of 731 442 SNPs were identified in 65 Asian psoriasis patients who were treated with adalimumab or infliximab. Here, we present 10 SNPs, such as those in JAG2 and ADRA2A, that were associated with treatment responses to anti‐TNF‐α agents (strongest effect, P < 7.11E‐06). This is the first GWAS to examine SNP associated with treatment responses in psoriasis patients. In addition, we identified other SNP that exhibited potential associations with anti‐TNF‐α treatment response, which merit further study. Of these, rs11096957 on TLR10, which is associated with increased TNF‐α production, was previously reported to be associated with treatment responses to TNF‐α inhibitors.Keywords
This publication has 47 references indexed in Scilit:
- Genome-wide association analysis of anti-TNF drug response in patients with rheumatoid arthritisAnnals of the Rheumatic Diseases, 2013
- Involvement of IL-9 in Th17-Associated Inflammation and Angiogenesis of PsoriasisPLOS ONE, 2013
- Notch Receptors and Smad3 Signaling Cooperate in the Induction of Interleukin-9-Producing T CellsImmunity, 2012
- TNFAIP3 Gene Polymorphisms Are Associated with Response to TNF Blockade in PsoriasisJournal of Investigative Dermatology, 2012
- Association analyses identify six new psoriasis susceptibility loci in the Chinese populationNature Genetics, 2010
- Lack of replication of genetic predictors for the rheumatoid arthritis response to anti-TNF treatments: a prospective case-only studyArthritis Research & Therapy, 2010
- Genome-wide association scan yields new insights into the immunopathogenesis of psoriasisGenes & Immunity, 2009
- Genetic Variation in Efflux Transporters Influences Outcome to Methotrexate Therapy in Patients with PsoriasisJournal of Investigative Dermatology, 2008
- PLINK: A Tool Set for Whole-Genome Association and Population-Based Linkage AnalysesThe American Journal of Human Genetics, 2007
- Analysis of linkage between lymphotoxin α haplotype and polymorphisms in 5′-flanking region of tumor necrosis factor α gene associated with efficacy of infliximab for Crohn's disease patientsMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2006